Screener
Nektar Therapeutics NKTR Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares designated or outstanding at March 31, 2026 or December 31, 2025, respectively | — | — |
| Common stock, $0.0001 par value; 390,000,000 shares authorized; 29,472,092 shares and 20,378,832 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 3 | 2 |
| Capital in excess of par value | 4,382,437 | 3,850,099 |
| Accumulated other comprehensive income (loss) | (1,034) | 17 |
| Accumulated deficit | (3,805,190) | (3,760,286) |
| Total stockholders’ equity | 576,216 | 89,832 |
| Total liabilities and stockholders’ equity | $763,271 | $280,406 |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's total equity?
- Nektar Therapeutics (NKTR) reported total equity of $576.22M in Q1 2026.
- How has Nektar Therapeutics's total equity changed year-over-year?
- Nektar Therapeutics's total equity increased by 4094.3% year-over-year, from $13.74M to $576.22M.
- What is the long-term trend for Nektar Therapeutics's total equity?
- Over 5 years (2020 to 2025), Nektar Therapeutics's total equity has grown at a -39.2% compound annual growth rate (CAGR), from $1.08B to $89.83M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Nektar Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude